NCT05725213View on ClinicalTrials.gov

ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

CompletedOBSERVATIONAL
Enrollment

224

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Actinic Keratoses
Interventions
DRUG

Metvix® 160 mg/g Creme

Patients are treated with Metvix creme and exposed to artificial daylight

Trial Locations (1)

45657

Klinikum Vest GmbH, Recklinghausen

All Listed Sponsors
lead

Galderma Laboratorium GmbH

INDUSTRY